Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. tumor specificity
Show results for
Products
Services
Applications

Companies

News
Articles

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Asia & Middle East
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Custom manufacturer
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Agriculture
  • Monitoring and Testing
  • Health and Safety
  • University / Academia / Research
  • Manufacturing, Other
Employees

  • 101-1000
  • 11-100

Tumor Specificity Suppliers & Manufacturers

41 companies found

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

based inCambridge, MASSACHUSETTS (USA)
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with ...
Intellia - Ex Vivo Therapies

Intellia - Ex Vivo Therapies

CONTACT SUPPLIER

NeraCare GmbH

NeraCare GmbH

based inFrankfurt, GERMANY
NeraCare develops and commercializes molecular diagnostic tests for patients with skin cancer. The tests provide actionable, tumor-specific information for each individual patient. The information is used to make improved treatment decisions, i.e. ...
CONTACT SUPPLIER

ORYX GmbH & Co. KG

ORYX GmbH & Co. KG

based inBaldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
ParvOryx - Oncolytic Parvovirus H1

ParvOryx - Oncolytic Parvovirus H1

CONTACT SUPPLIER

Elicio Therapeutics

Elicio Therapeutics

based inBoston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-002 - mKRAS Cancer Vaccine

Elicio - Model ELI-002 - mKRAS Cancer Vaccine

Our lymph node-targeted mKRAS cancer vaccine; Our Amphiphile (AMP)-powered lead candidate, ELI-002, generates a robust immune response against mutant Kristen rat sarcoma (mKRAS), with the potential to offer patients a stronger fight against the most ...
CONTACT SUPPLIER

Adicet Bio

Adicet Bio

based inMenlo Park, CALIFORNIA (USA)
Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and ...
Gamma delta T cells

Gamma delta T cells

The current engineered autologous alpha beta T cell products have shown significant efficacy in hematological malignancies; however comparable efficacy in solid tumors is yet to be proven. The cell platform and novel targeting ...
CONTACT SUPPLIER

NantOmics

NantOmics

based inMorrisville, NORTH CAROLINA (USA)
Our mission is to provide comprehensive personalized molecular solutions to inform cancer care. NantOmics, a member of the NantWorks ecosystem of companies, is a leader in molecular diagnostic testing and the first company to employ an integrated ...
CONTACT SUPPLIER

Treos Bio Limited

Treos Bio Limited

based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Treos - Personal Antigen Selection Calculator Technologies (PASCal)

Treos - Personal Antigen Selection Calculator Technologies (PASCal)

CONTACT SUPPLIER

Adaptimmune LLC

Adaptimmune LLC

based inPhiladelphia, PENNSYLVANIA (USA)
Adaptimmune, a leader in T-cell therapy, has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The Company's unique SPEAR (Specific Peptide Enhanced Affinity ...
Adaptimmune - T-Cell Therapies Technology

Adaptimmune - T-Cell Therapies Technology

CONTACT SUPPLIER

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics Ltd.

based inAbingdon, UNITED KINGDOM
PsiOxus is a clinical-stage company redefining therapies for solid tumors with the goal of curing patients with cancer. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor-localized production of combinations of ...
PsiOxus - Model T-SIGn - Viral Vector Platform Technology

PsiOxus - Model T-SIGn - Viral Vector Platform Technology

CONTACT SUPPLIER

POP Biotechnologies, Inc. (POP BIO)

POP Biotechnologies, Inc. (POP BIO)

based inBuffalo, NEW YORK (USA)
POP Biotechnologies, Inc. (POP BIO) is dedicated to addressing critical medical challenges with advanced nanotechnologies. POP BIO’s key breakthrough, the porphyrin-phospholipid (PoP) platform, facilitates the creation of powerful light-targeted ...
CONTACT SUPPLIER

ITM Isotope Technologies Munich SE

ITM Isotope Technologies Munich SE

based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
Targeted Radionuclide Therapy Services

Targeted Radionuclide Therapy Services

Targeted Radionuclide Therapy (TRT) or Peptide Receptor Radionuclide Therapy (PRRT) is a medical specialty using very small amounts of radioactive compounds, called radiopharmaceuticals, to diagnose and treat various diseases, like cancer. Once ...
CONTACT SUPPLIER

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.

based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
Greenwich - Model GP2 - Nine Amino Acid Transmembrane Peptide of the HER2/Neu Protein

Greenwich - Model GP2 - Nine Amino Acid Transmembrane Peptide of the HER2/Neu Protein

CONTACT SUPPLIER

NeoGenomics Laboratories

NeoGenomics Laboratories

based inFort Myers, FLORIDA (USA)
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with ...
RaDaR Residual Disease and Recurrence

RaDaR Residual Disease and Recurrence

RaDaR™ is a personalized, multi-tumor liquid biopsy assay that can track a set of up to 48 tumor-specific variants in a patient using a liquid biopsy with exceptional sensitivity. This ...
CONTACT SUPPLIER

Hookipa Pharma Inc.

Hookipa Pharma Inc.

based inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Immune System of Arenavirus Platform

Immune System of Arenavirus Platform

CONTACT SUPPLIER

Aphios Corporation

Aphios Corporation

based inWoburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios - Model APH-0912 - Combination of A Taxotere® Prodrug And Monoclonal Antibody

Aphios - Model APH-0912 - Combination of A Taxotere® Prodrug And Monoclonal Antibody

The prodrug is a combination of a docetaxel molecule, the potent anticancer drug, and a sugar molecule to enhance solubility covalently linked to a tumor-specific antibody. This molecular combination is not ...
CONTACT SUPPLIER

TheraBionic GmbH

TheraBionic GmbH

based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
TheraBionic - Model P1 device - Low Levels Radiofrequency (RF) Electromagnetic Device

TheraBionic - Model P1 device - Low Levels Radiofrequency (RF) Electromagnetic Device

The TheraBionic P1 produces low levels radiofrequency (RF) electromagnetic fields, which are amplitude-modulated at tumor-specific frequencies. The device is coupled with a spoon-shaped antenna, which is placed in ...
CONTACT SUPPLIER

NEC OncoImmunity AS 

NEC OncoImmunity AS 

based inOslo, NORWAY
NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer ...
NEC - Immune Profiler Software

NEC - Immune Profiler Software

CONTACT SUPPLIER

Zymeworks Inc

Zymeworks Inc

based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
Azymetric - Tailored Multifunctional Therapeutics

Azymetric - Tailored Multifunctional Therapeutics

Azymetric™ is the best-in-class platform for therapeutic antibodies that can simultaneously bind to multiple distinct locations on a target or to multiple targets, resulting in unique mechanisms of action not accessible through typical ...
CONTACT SUPPLIER

NexImmune, Inc.

NexImmune, Inc.

based inGaithersburg, MARYLAND (USA)
NexImmune is a clinical-stage biotechnology company developing unique approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation (AIMâ„¢) technology. AIM nanoparticles act as synthetic dendritic cells to deliver ...
AIM - ACT Adoptive Cellular Therapy

AIM - ACT Adoptive Cellular Therapy

NexImmune’s AIM™ platform is the foundation for our unique approach to immunotherapy. Our AIM nanoparticle technology enables the development of immunotherapies that orchestrate specific T cell function and trigger a ...
CONTACT SUPPLIER

ViciniVax BV

ViciniVax BV

based inGroningen, NETHERLANDS
ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines. Our first product candidate Vvax001, a therapeutic cancer vaccine ...
ViciniVax - Model Vvax001 - Therapeutic Cancer Vaccine

ViciniVax - Model Vvax001 - Therapeutic Cancer Vaccine

CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT